« Return to News | Drug Sponsors

Marina Biotech to close Cambridge site

Thursday, February 16, 2012 06:33 AM

Marina Biotech, a nucleic acid-based drug discovery and development company, will be closing its Cambridge, Mass., site and consolidating all R&D efforts at its headquarters in Bothell, Wash.

"This move will not affect the START-FAP trial as noted by our announcement of cohort II dosing. Further, we expect to continue to develop the tkRNAi platform in our labs in Bothell," said J. Michael French, president and CEO of Marina Biotech.

The individuals affected by the decision were all part of the former Cequent team, who helped develop CEQ508 and executed the START-FAP trial.

“I want to thank them for their efforts and wish them all well in their future endeavors," added French.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.